Kahraman S, Erul E, Gumusay O, Guven DC, et al. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in
Hormone Receptor-Positive/HER2-Negative Metastatic?Breast Cancer: Turkish
Oncology Group (TOG) Study. Clin Breast Cancer 2025 Mar 4:S1526-8209(25)00049.
PMID: 40190010
|